BridgeBio Pharma Shares Outstanding 2018-2024 | BBIO

BridgeBio Pharma shares outstanding for the quarter ending June 30, 2024 were 0.188B, a 16.85% increase year-over-year.

  • BridgeBio Pharma 2023 shares outstanding were 0.163B, a 10.39% increase from 2022.
  • BridgeBio Pharma 2022 shares outstanding were 0.147B, a 2.16% increase from 2021.
  • BridgeBio Pharma 2021 shares outstanding were 0.144B, a 22.34% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

BridgeBio Pharma Shares Outstanding 2018-2024 | BBIO

  • BridgeBio Pharma 2023 shares outstanding were 0.163B, a 10.39% increase from 2022.
  • BridgeBio Pharma 2022 shares outstanding were 0.147B, a 2.16% increase from 2021.
  • BridgeBio Pharma 2021 shares outstanding were 0.144B, a 22.34% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
Dr Reddy's Laboratories (RDY)$12.6B
Bausch Health Cos (BHC)$3.4B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$307M
Personalis (PSNL)$241M
Assembly Biosciences (ASMB)$106M
Grace Therapeutics (GRCE)$30M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$5M
Teligent (TLGT)$0M